Avalo Therapeutics (AVTX) Earnings Date & Reports

Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases... Show more

Industry: #Pharmaceuticals Other

Get AI intraday signals

A.I. Advisor

published Earnings

AVTX is expected to report earnings to fall 36.33% to -62 cents per share on July 30

Avalo Therapeutics AVTX Stock Earnings Reports

Q2'26

Est.

$-0.62

Q1'26

Beat

by $0.78

Q4'25

Beat

by $0.50

Q3'25

Missed

by $0.97

Q2'25

Missed

by $0.73

The last earnings report on May 13 showed earnings per share of -98 cents, beating the estimate of -175 cents. With 1.97M shares outstanding, the current market capitalization sits at 937.24M.

View a ticker or compare two or three

Compare

AVTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for AVTX